Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Earnings Watch For March 8 (ANN, FL, GCO)

Women's apparel retailer ANN Inc. (ANN: Quote) is expected to report results for the fourth quarter. The New York-based company's earnings are expected to decline sharply to $0.01 per share from $0.10 per share reported a year earlier, whereas quarterly revenues are anticipated to grow to $617.82 million from last year's $566.66 million. The shares closed Thursday at $29.00. (52-wk H/L $39.78/$23.93)

Specialty athletic retailer Foot Locker, Inc. (FL: Quote) is slated to report fourth-quarter results. The company is expected to post earnings of $0.73 per share, higher than the year-ago quarter's $0.55 per share. Also, the company is anticipated to generate revenues of $1.69 billion compared to $1.50 billion in the prior-year quarter. Shares of FL closed Thursday's trade at $35.31. (52-wk H/L $37.65/$27.86)

Nashville, Tennessee-based Genesco, Inc. (GCO: Quote) is scheduled to report fourth-quarter results. The specialty retailer is expected to post earnings of $2.12 per share, an increase from $1.97 per share a year ago, with revenues estimated at $774.51 million. The company's shares closed Thursday's regular trading at $61.17. (52-wk H/L $78.97/$50.33)

Click here to receive FREE breaking news email alerts for Ann Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Bundesbank President Jens Weidmann has criticized the European Central Bank's latest measures to boost the euro area economy, such as the planned purchases of covered bonds and asset-backed securities and covered bonds, as well as the interest rate reduction this month. The latest decisions suggest... European stocks are seen opening lower on Monday, tracking weak commodity prices and a subdued trend across the Asia-Pacific region as investors look ahead to Chinese manufacturing data due on Tuesday for important clues about China's growth outlook. China is experiencing stable growth and there... Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.